Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-06

FDA Approved: FROVATRIPTAN — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals NY LLC's original generic application for frovatriptan succinate tablets used to treat acute migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

ORIG AP for FROVATRIPTAN (FROVATRIPTAN SUCCINATE)